{"url_path":"/sec/plx/10-k/2026/item-9","section_key":"item-9","section_title":"Item 9 Changes in and Disagreements with Accountants on Accounting and Financial Disclosure","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-03-18","source_url":"https://www.sec.gov/Archives/edgar/data/1006281/0001104659-26-029858-index.html","accession_number":"0001104659-26-029858","cik":"0001006281","ticker":"PLX","issuer_name":"Protalix BioTherapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1006281/0001104659-26-029858-index.html","primary_entity_key":"0001006281","primary_entity_name":"Protalix BioTherapeutics, Inc."},"word_count":14,"has_tables":true,"body_markdown":"Item 9.      Changes in and Disagreements with Accountants on Accounting and Financial Disclosure\n\nNone."}